Metallothionein protein variants generated in rat liver as a result of DNA and RNA ethylations by the carcinogen diethylnitrosamine by Jauch, A. & Lutz, Werner K.




Metallothionein protein variants generated in rat liver as a result of DNA 
and RNA ethylations by the carcinogen diethylnitrosamine 
A. Jauch * and W.K. Lutz ** 
Institute of Toxicology, ETH and University of Zurich, CH-8603 Schwerzenbach (Switzerland) 
{Received 18 March 1986) 
{Revision received 3 June 1986) 
{Accepted 9 June 1986) 
Summary 
Metallothionein (MT) is a protein which contains 20 cysteine residues but no aromatic amino acids. It 
was tested whether treatment of male rats with the hepatocarcinogen diethylnitrosamine (DENA) could 
ethylate nucleic acids in such a way that protein variants containing measurable amounts of aromatic 
amino acid residues could be isolated from the livers of treated animals. To give a low Iimit of detection, 
the "wrong" amino acid precursors were administered in radiolabelled form at high Ievels of activity (7 
mCijkg each of [3H]tyrosine and [3H]phenylalanine). 11 p.Cijkg [14C]cysteine was given as an intemal 
marker for MT biosynthesis. 6 h after amino acid administration, metallothionein (MT) was isolated from 
the liver and extensively purified. Afteracid hydrolysis and collection of Cys, Tyr, and Phe from an HPLC 
analysis of the amino acids, the 3Hj14C ratio was determined. The carcinogen-treated rats exhibited a 
significantly higher ratio than the vehicle-treated animals. This type of in vivo assay might find interesting 
applications in the investigation of nucleic acid alkylations as promutagenic lesions. 
Since a !arge number of chemical carcinogens 
act by damaging DNA, many short-term screening 
tests for carcinogenicity are based upon the detec-
tion of mutational events. In the light of the recent 
findings that certain cellular proto-oncogenes can 
be activated by base Substitutions (refs. in Wein-
berg, 1985) the search for changes in amino acid 
composition of proteins could become a valuable 
tool. 
One majorproblern in proteinvariant analysis 
in non-clonal systems is the fact that minor 
changes in the relative abundance of the various 
amino acids in a small number of polypeptide 
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chains might not be significant due to the experi-
mental variability of the amino acid determina-
tions. The situation becomes much more clear-cut 
when a particular amino acid is lacldng in the 
wild-type polypeptide chain so that the mere pres-
ence of this amino acid provides evidence of a 
promutagenic lesion. 
We have shown earlier with cytochrome b5 that 
this approach is feasible if a low limit of detection 
of the wrong amino acid can be achieved with the 
use of radiolabel (Jauch and Lutz, 1983). The 
sensitivity of that system was, however, insuffi-
cient for toxicological purposes. Here, we present 
data on another protein, metallothioneiil (MT), 
where a polypeptide chain of 61 amino acids 
contains 20 cysteine (Cys) residues and Iacks 
aromatic amino acids (Kägi and Nordberg, 1979). 
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It will be shown that MT variants containing the 
aromatic amino acids tyrosine (Tyr) or phenyl-
alanine (Phe) can be isolated from rat liver after 
administration of a mutagenic carcinogen at a 
dose Ievel which would not have given rise to a 
significant effect in the older assay based on cyto-
chrome b5• 
Materials and methods 
Anima/s, chemica/s, and treatments 
Malerats (lva:SIV-50.SD) were from lvanovas, 
Kisslegg i. A., F .R. G. They were held 3 per macro-
lone cage on laboratory chow No. 343 (Klingen-
talmühle AG, Kaiseraugst, Switzerland) and tap 
water ad libitum. L-[2,3- 3H]Tyrosine (Tyr; 51 
Cijmmole), L-[2,3- 3HJphenylalanine (Phe; 40 Ci/ 
mmole) and L-[U-14 CJcysteine (Cys; 32.5 
mCijmmole) were purchased from the Radio-
chemical Centre, Amersham, Great Britain. N, N-
Diethylnitrosamine (DENA; CAS registry No. 55-
18-5) was from Fluka AG, Buchs, Switzerland. 
Unlabelled amino acids were from Serva, Heidel-
berg, F.R.G. All other reagents were of the highest 
purity available from Merck, Darmstadt, F.R.G. 
Three 5-week-old rats were treated for 4 weeks 
with 42 ~tl DENA/1 drinking water (correspond-
ing to an approximate dose of 4 mgjkg/day). 
Food was withdrawn on the last day at 06.00 h. At 
08.00 h, these rats received a single oral dose of 36 
mgjkg DENA in water. 3 control rats received 
water in the place of both subchronic and acute 
carcinogen treatments. At 10.00 hall animals were 
given a subcutaneous injection of CdC1 2 in 10- 4 
M HCI (1 mg Cd/rat) in the scapular region in 
order to induce MT synthesis (Andersen et al., 
1978). At 14.00 h a liquid synthetic diet was given 
by gavage (7.2 ml/kg) which contained 16% 
sucrose plus about one third of the daily require-
ment of all amino acids except the aromatic amino 
acids tyrosine and phenylalanine. These two amino 
acids were supplied in tritiated form at a Ievel of 
approximately 7 mCi/kg each ( exact dose given in 
Table 1). It was thought that a dietary Iack of Tyr 
and Phe could help to minimize the catabolism of 
these amino acids so that a transfer of tritium to 
other amino acids could be prevented as far as 
possible. Cys was 14C-marked (11 p.Cijkg) in order 
to have an intemal marker for the determination 
of the rate of MT biosynthesis. At 20.00 h the 
animals were killed under ether anaesthesia, the 
livers were removed and washed in ice-cold saline. 
Isolation of meta/Iothionein 
The liver was minced and homogenized with a 
Potter-Elvehjem-type glass-teflon device in 5 vol. 
0.25 M sucrose 10 mM Tris-HCl buffer pH 8.6 
with 10 strokes at 1000 rpm. A postmicrosomal 
supernatant was isolated after sequential centrifu-
gation with increasing force (5 min 300 X g; 5 min 
2000 X g; 5 min 10000 X g; 5 min 20000 X g and 
60 min 105 000 x g ). After removing the fatty layer 
on the top, the clear reddish supernatant was 
decanted and gassed for 10 min with N2. The . 
solution was partially heat-denatured under nitro-
gen for 1 min at 70°C. This procedure precipi-
tated 60-70% of the high molecular 3H activity, 
but should not have precipitated Cd-rieb MT 
(Cherian, 1974). The heat-stable supematant as 
weil as all subsequent MT preparations were al-
ways kept under N2 atmosphere at 4°C between 
the various purification procedures. Lyophilized 
protein was stored at - 20 ° C. The samples were 
lyophilized, redissolved in 4 ml water, loaded on a 
Sephadex G-75-SF column (2.5 cm X 80 cm; 
Pharmacia) and eluted with 10 mM Tris-HCl 
buffer, pH 8.6. The elution of MT and of protein· 
in generat was monitared by determination of (a) 
Zn and Cd by atomic absorption spectrometry 
(Perkin-Elmer atomic absorption spectrophoto-
meter 5000 equipped with a HGA 5000 graphite 
furnace), (b) 14 C and 3H radioactivity by dual-labei 
scintillation counting, and (c) the optical density 
at 280 nm in each fraction. MT eluted at ~/Yc> 
values between 1.6 and 2.0 as described by Chen 
et al. (1975). The high-molecular protein eluting at 
the solvent front was also collected for the de-
termination of the average specific activity of cy-
tosolic protein. A pool of approx. 70. ml con-
taining the MT was concentrated by ultrafiltration 
with a Diaflo YM 2 membrane (Amicon) to 10 ml, 
loaded on a DEAE-Sephacel column (Pharmacia; 
0.9 cm X 19 cm) and eluted with a linear Tris-HCI 
3radient (10-200 mM J'ris-HCl, pH 8.6, total 250 
ml). This chromatography will later be referred to 
as DEAE chromatography type A. It separates the 
two known MT isoproteins MT1 and MT2 (Shaikh 
and Lucis, 1971) from MT dimers and partially 
metal-depleted forms. MT peaks eluting at a 
Tris-HCI concentration below 110 mM were 
pooled and lyophilized, and the Cys residues were 
methylcarboxylated with iodoacetic acid accord-
ing to Crestfield et al. (1963) with the following 
modifications. The reaction was carried out under 
N2 atmosphere. 10 mg each of Tyr and Phe in 
unlabelled form and 35 ~tl 2-mercaptoethanol were 
added in order to keep a reaction with the labelled 
amino acids Tyr and Phe to a minimum. EDTA 
was added immediately after iodoacetic acid in 
order to complex the metal ions set free from the 
protein after the modification of the Cys residues. 
An additional 65 ~tl 2-mercaptoethanol was added 
after 4 min in order to trap unreacted iodoacetic 
acid and to stop the reaction. The mixture was 
dialyzed (Berghof SpectrajPor 3, cutoff mol. wt. 
3500, Innovativ Labor, Adliswil, Switzerland) 
against 100 vol. of 10 mM Tris-HCI, pH 8.6, 
ultrafittered and loaded again on DEAE-Sepha-
cel. The column was eluted with a linear salt 
gradient to 400 mM NaCl, 50 mM Tris-HCI, pH 
7.5 with a total of 200 ml huffer solution ( = DEAE 
chromatography, type B). Most of the contaminat-
ing protein eluted early and tailed only slightly 
into the peak of methylcarboxylated MT (MT-
CH2-COOH) which eluted at about 255 mM 
NaCI. Of each MT peak, the front 15% and the 
tail 5% of the 14C activity were discarded. The 
chromatography was repeated twice, whereafter 
the 3Hj14C ratio, an indicator of the purity of the 
MT samples, remained constant. The last pool of 
pure MT -CH2-COOH was dialyzed and lyophi-
lized. 5 nmoles of both unlabelled Tyr and Phe 
were added as carrier and the protein was hydro-
lysed in 6 N HCI for 20 h at 112° C. The resulting 
amino acid mixture was separated by HPLC 
according to Hughes et al. (1982) and the fractions 
containing Cys-CH 2-COOH (fraction No. 5), 
cystine (Nos. 9 and 10), Tyr (No. 12) and Phe 
(No. 14) were collected and counted for 14C and 
3 H radioactivity. The background count was 
determined from amino acid Separations of mix-
tures of unlabelled Standards. The net counts were 
used for the calculation of mutation indices as 
defined in a footnote to Table 1. 
Determination of specific activities 
Protein content was determined with the Polin 
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reagent. Liquid scintillation counting was per-
fonned with samples mixed with Insta-Gel scintil-
lation cocktail (Packard) in low background glass 
vials (Packard) in a Packard Tri Carb 460. CD 
scintillation counter. The activity of double-
labelled samples was determined after subtraction 
of an adequate background activity and on the 
basis of a quench-indicating parameter calibrated 
with intemally standardized samples. Vials were 
kept in the dark at 4°C for at least 1 day before 
being counted for up to 4 X 30 min. 
Results 
The 3 DENA-treated rats showed a slightly 
depressed weight gain during the 4-week pretreat-
ment period and a reduced liver weight as com-
pared with the controls (lines 1 and 4 of Table 1). 
Protein synthesis was, however, not affected by 
the carcinogen treatment as documented by the 
incorporation of labelled amino acids into protein 
synthesized during the 6-h lag between adminis-
tration and sacrifice (lines 5 and 6). No difference 
was seen either in MT biosynthesis (line 7). Non-
MT protein collected from the front of the first 
Sephadex chromatography had average specific 
activities of 250000 dpm 3H and 370 dpm 14C per 
mg. The high Ievel of 14 C incorporation into MT 
was due to the fact that this polypeptide contains 
about 15 times more Cys residues than an average 
protein and that the rate of synthesis was higher 
than average because it bad been stimulated by 
prior administration of cadmium. 
The 3Hj14C ratiowas used to measure the MT 
purity. This is possible because the wild-type poly-
peptide contains neither Tyr nor Phe (tritiuin Iabel) 
but 20 Cys residues e4C Iabel) so that the 3Hj14C 
ratio should reach a minimum upon exhaustive 
purification. This ratio started with a value of 
about 700 for high-molecular cytosolic protein 
and reaclied Ievels of around 0.2 for MT after the 
second DEAE chromatography type B. No further 
reduction could be achieved by an additional 
DEAE step. The individual purification steps 
served different purposes and were of various 
efficiency. Heat denaturation and Sephadex chro-
matography both resulted in an overall purifica-
tion by a factor of about 2. DEAE type A chro-
matography was rather ineffective with respect to 
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purification but was a prerequisite specifically to 
remove those proteins which elute in the range 
where carboxymethylated MT was expected to 
elute in a later stage. The best purification was 
possible after chemical modification of MT. 
Thanks to the exceptional abundance of Cys 
residues which are easily modified by carboxy-
methylation ( thereby increasing the number of 
acidic groups), the first DEAE chromatography of 
TABLE 1 
type B resulted in a reduction of the 3Hj14C ratio 
by a factor of about 100. The final MT-CH 2-
COOH pool exhibited a ratio which was about 
3500 times lower than that of . cytosolic high-
molecular weight protein. lf it is assumed that the 
average protein contains 2% Cys and 3% Tyr + 
Phe, whereas MT contains 30% Cys, then it can be 
deduced that the presence of Tyr and Phe in MT 
must be below 0.01% (30 : 2 x 3 : 3500). This 
INCORPORATION OF [14 C]Cys, eHJTyr AND eH]Phe INTO METALLOTHIONEIN ISOLATED FROM LIVER CYTOSOL 
AFTER TRFATMENT OF MALE SPRAGUE-DAWLEY RATS WITH THE HEPATOCARCINOGEN DIETHYLNITROSA-
MINE 
Treatment Controls Diethylnitrosamine 
Anirnal weight 
at sacrifice (g) 331 288 316 270 298 310 
[ 14 CJCys administered 
(JA.Ci/kg) 11.7 12.0 
[ 3H](Tyr plus Phe, 1: 1) 
10.6 12.4 11.6 9.6 
administered (mCjjkg) 14.6 14.2 13.2 15.5 14.4 12.6 
Liver weight (g) 14.9 12.6 14.8 11.1 11.4 11.3 
Amino acid incorporation a 
into cytosolic protein 
3H 19.2 17.8 18.1 18.0 17.9 15.2 
I4c 23.1 39.1 33.3 35.6 32.9 32.7 
into metallothionein b,c 
I4c 4031 3471 ~293 3735 3078 3081 
Arnount of MT -CH 2 -COOH 
separated by AAA c (nmoles) 29.4 18.1 16.0 10.5 35.0 21.5 
Cys-CH2 -COOH + cystine 
in AAA ( dpm 14 C) 9030 4810 3630 3050 7830 3990 
Tyr in AAA ( dpm 3 H) 55.4 32.2 24.5 35.9 62.8 95.7 
Phe in AAA (dpm 3H) 113 60.2 48.6 56.4 89.6 96.6 
Mutationindex d 
For Tyr 6.1 6.7 6.8 11.8 8.0 24.0 
Mean±S.D. 6.5±0.3 14.6± 8.4 
For Phe 12.5 12.5 13.4 18.5 11.5 24.2 
Mean±S.D. 12.8 ±0.5 18.1 ± 6.4 
Normalized e 6.4 6.4 6.8 9.4 5.9 12.3 
a Calculated from the specific activity of protein (dpm/.ug) divided by the dose of radioactivity administered (mCijkg). 
b Determined on the basis of the pure MT-CH 2 -COOH sarnple hydrolysed for the arnino acid analysis (AAA). 
c The arnount of MT -CH 2 -COOH hydrolysate separated by HPLC for amino acid analysis (AAA) was determined on the basis of 
the methionine peak known to represent 1 amino acid residue and a molecular weight of 7442 taken as an average of the two main 
MT isoproteins MTl and MT2 (Wong and Klaassen, 1979). · 
d 
xl0- 3; Tyr index: [3H]dpm Tyr/[14 C]dpm Cys-CH 2 -COOH+cystine; Phe index: [3H]dpm Phe/[14 C]dpm Cys-CH 2 -COOH 
+ cystine. 
e Obtained by multiplying the individual mutation indices for Phe with the ratio of the rneans obtained in the control group for Tyr 
and Phe (example: 12.5 X 6.5/12.8 = 6.4; calculations have been performed with more than 2 digits). 
estimation only holds if the possibility of tritium 
becoming incorporated into other amino acids re-
mains negligible. Such a tritium shift is possible, 
however, because of the metabolic instability of 
the 2,3-tritium markers in Tyr and Phe. Other 
amino acids can become radiolabelled, e.g., after 
degradative deamination of Tyr which produces 
tritiated pyridoxamine phosphate, a cofactor used 
for general amino transfer reactions. Although the 
degradation of Phe and Tyr was reduced as far as 
possible by administration of a liquid diet lacking 
these two amino acids, the process is not com-
pletely avoidable. This form of biosynthetic tritia-
tion of MT cannot, therefore, be excluded on the 
basis of the radioactivity of the polypeptide. Clear 
results can be expected alter amino acid analysis 
(AAA) where only that radioactivity which coe-
lutes with the optical density of the unlabelled 
standards is taken to represent Tyr or Phe. 
The data given in Table 1 show that at the 
elution times of Tyr and Phe some 3H activity was 
detected in all 6 samples (lines 10 and 11). The 
combined peaks of carboxymethylated cysteine 
and of cystine were highly 14 C labelled and served 
as a quantitative indicator for the MT synthesis of 
each individual animal. The ratio of these values 
( division by the values in line 9) was named 
mutation index in Table 1 and represents the 
extent of incorporation of Tyr and Phe into MT 
synthesized during that period of time when radio-
labelled amino acids were available. The individ-
ual values for the 3 control animals revealed very 
small variability for both indices Tyr and Phe, 
whereas the carcinogen;.treated animals, firstly, 
yielded higher indices ( except for one Phe value 
which was at control Ievel) and, secondly, ex-
hibited significantly Iarger variability within the 
groups (F test). Comparison of the combined Tyr 
plus Phe data for treated vs. control animals with 
the Wilcoxon rank sum test revealed a Ievel of 
significance of p < 0.05, showing that the car-
cinogen treatment resulted in a significantly in-
creased incorporation of "wrong" amino acids. 
The fact that the Tyr and Phe peaks collected 
from the amino acid analysis of the control rats 
were also radiolabelled • to a minor extent raises 
the question about the specificity of the mutation 
assay presented. Bither the MT samples used for 
the amino acid analysis were still contaminated 
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with non-MT protein or it must be concluded that 
the control animals did not have an error-free 
protein synthesis. Miscodings might for instance 
have been induced by the administration of Cd 
which was given io ai1 animals in order to stimu-
late MT synthesis. A mutagenic activity of Cd bad 
been reported in a nurober of systems, some of 
which detect basepair Substitutions (refs. in Ochi 
et al., 1984). Both modes of contamination cannot, 
however, explain the difference between the two 
groups so that the DENA treatment must have 
been responsible for the effect. 
Discussion 
We have shown that the treatment of rats with 
an ethylating carcinogen can result in detectable 
changes in the amino acid composition of a pro-
tein. Prerequisite is a weil characterized protein 
lacking one or more amino acids in the wild type. 
The present assay, based on testing such changes 
in metallothionein, is more sensitive than the one 
with cytochrome b5 described previously (Jauch 
and Lutz, 1983) because of the following ad-
vantages: Firstly, the rate of MT synthesis can be 
stimulated by administration of metal ions, par-
ticularly cadmium. The induced rate of synthesis 
can reach values of 2-3 nmoles/h/g liver (Ander-
sen et al., 1978), i.e., 20-30 times higher than the 
rate of cytochrome b5 synthesis and at least 10 
times higher than for the average cytosolic liver 
protein. It should be mentioned here that it is not 
the total amount of a specific protein chain in the 
cell which is important for the Iimit of detection 
of variants in this type of assay but the rate of 
synthesis during that time period when the radio-
labelled "wrong" amino acids are available for 
incorporation. Secondly, both Tyr and Phe are 
coded for by triplets which have 2 bases in com-
mon with triplets coding for Ser or Cys. Since the 
latter aniino acids represent about 50% of all 
residues in MT, the probability of a detectable 
amino acid substitution becomes relatively high. 
A complete analysis of a1I theoretically possible 
steps which Iead to incorporation of Tyr or · Phe 
into MT has been compiled elsewhere (Jauch, 
1984). Suffice to say here that the most important 
contribution for Tyr expression comes from an 
ethylation of guaninein mRNA in the UGC and 
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UGU triplets coding for Cys. Miscoding of 0 6-
ethylguanine in RNA with uracil instead of cyto-
sine in tRN A would Iead to the incorporation of 
Tyr into the polypeptide chain. After a single dose 
of 36 mg DENA/kg body weight, there will be 
about one 0 6-ethylguanine per 105 DNA guanines, 
at a time between 6 and 12 h after oral adminis-
tration (Scherer et al., 1977). A similar Ievel of 
RNA darnage can be expected (Lutz, 1979). A 
maximum rate of variant Tyr incorporation of 
20/2 x 10- 5 = 10-4 can be calculated from the 
two triplets coding for 20 Cys residues in MT. 
This means that about one out of 104 newly 
synthesized MT chains would have one Tyr incor-
porated. With similar estimates for the remaining 
possibilities for erroneous transcription and trans-
lation (Jauch, 1984), a total theoretical probability 
for a Tyr is about one in 3000 MT molecules. This 
Tyr frequency is alone about 10 times higher than 
could be expected by a similar estimate with the 
cytochrome b5-methionine assay. 
The experimental frequency reported here is 
astonishingly close: The average net mutation in-
dex for Tyr was 0.0146-0.0065 = 0.0081 dpm 
Tyr I dpm Cys. Taken that about 622 times more 
radiolabet was administered in the form of Tyr as 
compared with Cys, and knowing that MT con-
tains 20 Cys residues, the frequency of Tyr can be 
calculated to be 0.0081 x 20: 622 = 2.6 x 10- 4• 
This means that one out of 3800 MT chains 
contained a DENA treatment-related Tyr. 
A similar estimate for Phe shows that the most 
important contribution comes from DNA-guanine 
ethylations in AGA and AGG triplets coding for 
Ser. It was not attempted in this case to compare 
theoretical and experimental mutation frequencies 
because it was considered impossible to estimate 
the mutational consequences on the DNA Ievel of 
the chronic administration of DEN A in the drink-
ing water. 
The quantitative comparison of theoretical and 
experimental results for Tyr as described above 
can only be regarded as a first attempt. Overesti-
mations must result from the assumption that the 
0 6-ethylated guanine miscodes 100% with the base 
coding for the wrong amino acid. It has also been 
assumed that the specific activities of Tyr, Phe 
and Cys incorporated into protein are propor-
tional to the administered radioactivities. 
Our results demoostrate that the potency of 
genotoxic carcinogens to induce premutationalle-
sions can, in principle, be determined in vivo. 
Both assays, the one based on cytochrome b5 
reported previously and the one based on metal-
lothionein described here, could also reveal organ 
specificities of carcinogens because both proteins 
are widely distributed in several tissues (Onosaka 
and Cherian, 1981, for MT). The present assay is 
markedly more sensitive. Additional improve-
ments could be obtained by modifications of the 
protein purification method for higher yield, higher 
purity, and faster isolation. This could increase the 
applicability of the assay as a tool in genetic 
toxicology testing but much work remains to be 
done in order to discriminate between the effects 
of single versus repeated administrations and to 
distinguish between the contributions of RNA 
alkylations, DNA alkylations, and mutations. 
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